Global Hemoglobin A1c Testing Devices Market - Forecast to 2019: Major companies include Abbott Laboratories, Alere, Arkray, Danaher and Bio-Rad

DUBLIN, May 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/pmg352/hemoglobin_a1c) has announced the addition of the "Global Hemoglobin A1c Testing Devices Market - Forecast to 2019: Major companies include Abbott Laboratories, Alere, Arkray, Danaher and Bio-Rad" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient's blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients. Since A1C test reflects the average amount of glucose for the past 2 to 3 months, it is opined to be more reliable than conventional blood glucose test.

Physicians are increasingly prescribing HbA1c test to their patients which will lead to an increase in the test volume. Moreover, rising diabetes incidence rate is a major driver for the HbA1c testing market. With growing awareness about prevention and management of diabetes, the demand for HbA1c testing devices will rise rapidly especially in the Asia-Pacific, Latin America, Middle East and African regions.

Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013 and Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With this diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes.

Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster pace during the forecast period.

Based on technologies, the hemoglobin A1c testing devices market is further categorized into five segments, namely, ion-exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay and others. The boronate affinity chromatography market will be growing at a faster pace during the forecast period as this technology has no interference from hemoglobin variants and is also used in both laboratory as well as point-of-care testing. Healthcare practitioners are recommending the use of devices which offer least variant interference and this would elevate the demand for boronate affinity chromatography in HbA1c testing.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview

Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use

Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology

Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography

Chapter 7 Recommendations

Chapter 8 Company Profiles

Companies Mentioned:

• Abbott Laboratories
• Alere, Inc.
• ARKRAY, Inc.
• Bio-Rad Laboratories, Inc.
• Chek Diagnostics (Polymer Technology Systems, Inc.)
• Danaher Corporation (Beckman Coulter)
• EKF Diagnostics Holdings plc
• F. Hoffmann-La Roche Ltd.
• Menarini Group
• Sebia
• Siemens Healthcare
• Tosoh Corporation
• Trinity Biotech plc

For more information visit http://www.researchandmarkets.com/research/pmg352/hemoglobin_a1c

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net